| Dr John Irving Miller, MD | |
|
1650 Grand Concourse, Bronx, NY 10457-7606 | |
| (718) 901-8988 | |
| Not Available |
| Full Name | Dr John Irving Miller |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 45 Years |
| Location | 1650 Grand Concourse, Bronx, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285788265 | NPI | - | NPPES |
| 01027412 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 160105 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York University Langone Medical Center | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
| Bronxcare Health System | 3870404429 | 270 |
| Nyu Langone Hospitals | 4981515699 | 203 |
News Archive
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
Stefan Remy and colleagues at the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn have illuminated how this system works. "The system acts like a filter, only letting the most important impulses pass," explains Remy. "This produces the targeted neuronal patterns that are indispensible for long-term memory storage."
Traumatic brain injury has entered the public's consciousness as the silent, signature wound brought back by many of our military warriors from Iraq and Afghanistan. But such injuries don't only happen in warfare, they happen to civilians too. Think car crashes, a slip and fall, two football players colliding helmet to helmet.
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
› Verified 2 days ago
| Entity Name | Tjh Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184670465 PECOS PAC ID: 8527960533 Enrollment ID: O20040121000802 |
News Archive
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
Stefan Remy and colleagues at the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn have illuminated how this system works. "The system acts like a filter, only letting the most important impulses pass," explains Remy. "This produces the targeted neuronal patterns that are indispensible for long-term memory storage."
Traumatic brain injury has entered the public's consciousness as the silent, signature wound brought back by many of our military warriors from Iraq and Afghanistan. But such injuries don't only happen in warfare, they happen to civilians too. Think car crashes, a slip and fall, two football players colliding helmet to helmet.
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
› Verified 2 days ago
| Entity Name | Neuroaxis Neurosurgical Assoc Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952573644 PECOS PAC ID: 7113818238 Enrollment ID: O20040320000112 |
News Archive
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
Stefan Remy and colleagues at the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn have illuminated how this system works. "The system acts like a filter, only letting the most important impulses pass," explains Remy. "This produces the targeted neuronal patterns that are indispensible for long-term memory storage."
Traumatic brain injury has entered the public's consciousness as the silent, signature wound brought back by many of our military warriors from Iraq and Afghanistan. But such injuries don't only happen in warfare, they happen to civilians too. Think car crashes, a slip and fall, two football players colliding helmet to helmet.
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
› Verified 2 days ago
| Entity Name | Bronxcare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245390855 PECOS PAC ID: 3870404429 Enrollment ID: O20040526001082 |
News Archive
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
Stefan Remy and colleagues at the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn have illuminated how this system works. "The system acts like a filter, only letting the most important impulses pass," explains Remy. "This produces the targeted neuronal patterns that are indispensible for long-term memory storage."
Traumatic brain injury has entered the public's consciousness as the silent, signature wound brought back by many of our military warriors from Iraq and Afghanistan. But such injuries don't only happen in warfare, they happen to civilians too. Think car crashes, a slip and fall, two football players colliding helmet to helmet.
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
› Verified 2 days ago
| Entity Name | Nassau Health Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902822992 PECOS PAC ID: 2961315221 Enrollment ID: O20040619000043 |
News Archive
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
Stefan Remy and colleagues at the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn have illuminated how this system works. "The system acts like a filter, only letting the most important impulses pass," explains Remy. "This produces the targeted neuronal patterns that are indispensible for long-term memory storage."
Traumatic brain injury has entered the public's consciousness as the silent, signature wound brought back by many of our military warriors from Iraq and Afghanistan. But such injuries don't only happen in warfare, they happen to civilians too. Think car crashes, a slip and fall, two football players colliding helmet to helmet.
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
› Verified 2 days ago
| Entity Name | Nyu Langone Hospitals |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790975944 PECOS PAC ID: 4981515699 Enrollment ID: O20050721000058 |
News Archive
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
Stefan Remy and colleagues at the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn have illuminated how this system works. "The system acts like a filter, only letting the most important impulses pass," explains Remy. "This produces the targeted neuronal patterns that are indispensible for long-term memory storage."
Traumatic brain injury has entered the public's consciousness as the silent, signature wound brought back by many of our military warriors from Iraq and Afghanistan. But such injuries don't only happen in warfare, they happen to civilians too. Think car crashes, a slip and fall, two football players colliding helmet to helmet.
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
› Verified 2 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
Stefan Remy and colleagues at the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn have illuminated how this system works. "The system acts like a filter, only letting the most important impulses pass," explains Remy. "This produces the targeted neuronal patterns that are indispensible for long-term memory storage."
Traumatic brain injury has entered the public's consciousness as the silent, signature wound brought back by many of our military warriors from Iraq and Afghanistan. But such injuries don't only happen in warfare, they happen to civilians too. Think car crashes, a slip and fall, two football players colliding helmet to helmet.
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
› Verified 2 days ago
| Entity Name | Kingsbrook Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104112838 PECOS PAC ID: 8729252028 Enrollment ID: O20111123000332 |
News Archive
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
Stefan Remy and colleagues at the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn have illuminated how this system works. "The system acts like a filter, only letting the most important impulses pass," explains Remy. "This produces the targeted neuronal patterns that are indispensible for long-term memory storage."
Traumatic brain injury has entered the public's consciousness as the silent, signature wound brought back by many of our military warriors from Iraq and Afghanistan. But such injuries don't only happen in warfare, they happen to civilians too. Think car crashes, a slip and fall, two football players colliding helmet to helmet.
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Irving Miller, MD Po Box 74 7821, Rego Park, NY 11374 Ph: (718) 459-7700 | Dr John Irving Miller, MD 1650 Grand Concourse, Bronx, NY 10457-7606 Ph: (718) 901-8988 |
News Archive
Doctors.net.uk, a professional networking site, found that 593 (54%) of the 1,096 doctors who took part in the self-selecting survey answered yes when asked: "Should the NHS be allowed to refuse non-emergency treatments to patients unless they lose weight or stop smoking?" They believe unhealthy behaviour can make procedures less likely to work, and that the service is not obliged to devote scarce resources to them.
Stefan Remy and colleagues at the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn have illuminated how this system works. "The system acts like a filter, only letting the most important impulses pass," explains Remy. "This produces the targeted neuronal patterns that are indispensible for long-term memory storage."
Traumatic brain injury has entered the public's consciousness as the silent, signature wound brought back by many of our military warriors from Iraq and Afghanistan. But such injuries don't only happen in warfare, they happen to civilians too. Think car crashes, a slip and fall, two football players colliding helmet to helmet.
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,592,441 to Rosetta Genomics. The patent relates to human microRNA miR-193b, as well as to complementary probes and vectors. This is the third patent issued to Rosetta Genomics by the USPTO.
› Verified 2 days ago
Neil Haranhalli, MD Neurological Surgery Medicare: May Accept Medicare Assignments Practice Location: 3316 Rochambeau Ave, Bronx, NY 10467 Phone: 718-920-7400 | |
Dr. Merritt Drew Kinon, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-7400 | |
David S Gordon, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: Mmc - Dept. Of Neurosurgery, 3316 Rochambeau Avenue, Bronx, NY 10467 Phone: 718-920-7479 | |
Dr. Kathryn R Ko, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3rd Avenue And 183rd Street, St. Barnabas Hospital, Bronx, NY 10457 Phone: 718-960-3788 | |
Dr. D. Roxanne Todor, Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1400 Pelham Pkwy S, Bronx, NY 10461 Phone: 718-918-3060 | |
Eugene S Flamm, MD Neurological Surgery Medicare: May Accept Medicare Assignments Practice Location: Mmc - Dept. Of Neurosurgery, 3316 Rochambeau Avenue, Bronx, NY 10467 Phone: 718-904-4053 | |
Dr. Nrupen Baxi, MD Neurological Surgery Medicare: May Accept Medicare Assignments Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-7498 |